Top

Supportive Care in Cancer

Published in:

01-12-2021 | Psycho-oncology | Original Article

Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic

Authors: Nienke Zomerdijk, Michelle Jongenelis, Camille E. Short, Andrew Smith, Jane Turner, Kathryn Huntley

Published in: Supportive Care in Cancer | Issue 12/2021

Abstract

Background

The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions.

Methods

Three hundred and ninety-four respondents volunteered their participation in response to a study advertisement distributed online through established haematology groups. Participants completed a self-report online survey exploring wellbeing, psychological distress, unmet supportive care needs, and fear of cancer recurrence.

Results

At least 1 in 3 respondents (35%) reported clinical levels of distress and nearly 1 in 3 (32%) identified at least one unmet need. Among respondents in remission (n = 134), clinical fear of cancer recurrence was reported by nearly all (95%). Unmet needs, pre-existing health conditions, younger age, financial concerns, and perceived risk of contracting COVID-19 were the dominant factors contributing to psychological distress during the pandemic. Psychological distress, lost income, perceived inadequate support from care team, perceived risk of contracting COVID-19, and being a woman were significantly associated with unmet needs. Psychological distress and concern about the impact of COVID-19 on cancer management were significantly associated with fear of cancer recurrence among respondents in remission.

Conclusion

Results highlight the high psychological burden and unmet needs experienced by people with haematological cancers during the COVID-19 pandemic and indicate a need for innovative solutions to rapidly identify distress and unmet needs during, and beyond, pandemic times.

Available only for authorised users

Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu C-Y, Desai A, de Lima Lopes D Jr (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395(10241):1907–1918CrossRef

Weinkove R, McQuilten Z, Adler J, Agar M, Blyth E, Cheng A, Conyers R, Haeusler G, Hardie C, Jackson C (2020) Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust 212(10):481–489. https://doi.org/10.5694/mja2.50607CrossRefPubMedPubMedCentral

American College of Emergency Physicians (2020) COVID-19.https://www.emergencyphysicians.org/globalassets/emphysicians/all-pdfs/acep-mc-COVID19-april-poll-analysis.pdf. Accessed 28 November 2020

Monash Partners Comprehensive Cancer Consortium (2020) Victoria launches safe cancer care campaign for patients. https://www.monashpartnersccc.org/news/victoria-launches-safe-cancer-care-campaign-for-patients. Accessed 6 May 2020

Dinmohamed AG, Visser O, Verhoeven RH, Louwman MW, van Nederveen FH, Willems SM, Merkx MA, Lemmens VE, Nagtegaal ID, Siesling S (2020) Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol 21(6):750–751. https://doi.org/10.1016/S1470-2045(20)30265-5CrossRefPubMedPubMedCentral

Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, Rachet B, Aggarwal A (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21(8):1023–1034. https://doi.org/10.1016/S1470-2045(20)30388-0CrossRefPubMedPubMedCentral

Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, O’Sullivan DE, Booth CM, Sullivan R, Aggarwal A (2020) Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371:m4087. https://doi.org/10.1136/bmj.m4087CrossRefPubMed

Chen G, Wu Q, Jiang H, Zhang H, Peng J, Hu J, Chen M, Zhong Y, Xie C (2020) Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19. Psycho-oncol 29:1395–1398. https://doi.org/10.1002/pon.5451CrossRef

Swainston J, Chapman B, Grunfeld EA, Derakshan N (2020) COVID-19 lockdown and its adverse impact on psychological health in breast cancer. Front Psychol 11:2033. https://doi.org/10.3389/fpsyg.2020.02033CrossRefPubMedPubMedCentral

10.

Edge R, Mazariego C, Li Z, Canfell K, Miller A, Koczwara B, Shaw J, Taylor N (2021) Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services. Support Care Cancer:1-11. https://doi.org/10.1007/s00520-021-06101-3

11.

Leach CR, Kirkland EG, Masters M, Sloan K, Rees-Punia E, Patel AV, Watson L (2021) Cancer survivor worries about treatment disruption and detrimental health outcomes due to the COVID-19 pandemic. J Psychosoc Oncol:1–16

12.

World Ovarian Cancer Coalition, World Pancreatic Cancer Coalition, Lymphoma Coalition, Advanced Breast Cancer Global Alliance, Coalitions WBCP (2020) The impact of COVID-19 on cancer patient organisations https://worldovariancancercoalition.org/wp-content/uploads/2020/06/The-impact-of-COVID-19-on-Cancer-Patient-Organisations-12th-June-2020-FINAL.pdf. Accessed 11 November 2020

13.

Eichenberger EM, Soave R, Zappetti D, Small CB, Shore T, van Besien K, Douglass C, Westblade LF, Satlin MJ (2019) Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 54(7):1058–1066. https://doi.org/10.1038/s41409-018-0386-zCrossRefPubMed

14.

Lee LY, Cazier J-B, Starkey T, Briggs SE, Arnold R, Bisht V, Booth S, Campton NA, Cheng VW, Collins G (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol 21(10):1309–1316. https://doi.org/10.1016/S1470-2045(20)30442-3CrossRefPubMedPubMedCentral

15.

Leukaemia Foundation (2020) National Strategic Action Plan for Blood Cancer. https://www.leukaemia.org.au/national-action-plan. Accessed 19 November 2020

16.

Purtill J (2020) Graham is waiting on lifesaving stem cell treatment. Coronavirus is stopping delivery. Australian Broadcasting Company. https://www.abc.net.au/triplej/programs/hack/stem-cell-transplants-coronavirus/12070468. Accessed 6 May 2020

17.

Mengling T, Rall G, Bernas SN, Astreou N, Bochert S, Boelk T, Buk D, Burkard K, Endert D, Gnant K, Hildebrand S, Köksaldi H, Petit I, Sauter J, Seitz S, Stolze J, Weber K, Weber M, Lange V, Pingel J, Platz A, Schäfer T, Schetelig J, Wienand E, Geist S, Neujahr E, Schmidt AH (2020) Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS. Bone Marrow Transplant. https://doi.org/10.1038/s41409-020-01138-0CrossRefPubMedPubMedCentral

18.

Lloyd M (2020) Australia scrambles to save blood cancer patients as COVID-19 border closures delay foreign cell transplants. ABC News.https://www.abc.net.au/news/2020-09-24/covid-19-border-closure-forces-stem-cell-transplant-workaround/12688108. Accessed 23 November 2020

19.

Australian Bureau of Statistics (2016) Australian Standard Geographical Classification (ASGC) Volume 5 Remoteness Structure. ABS. http://www.abs.gov.au. Accessed 4 September 2020

20.

Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, Howes MJ, Normand S-LT, Manderscheid RW, Walters EE (2003) Screening for serious mental illness in the general population. Arch General Psychiatry 60(2):184–189. https://doi.org/10.1001/archpsyc.60.2.184CrossRef

21.

Boyes A, Girgis A, Lecathelinais C (2009) Brief assessment of adult cancer patients’ perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). J Eval Clin Pract 15(4):602–606. https://doi.org/10.1111/j.1365-2753.2008.01057.xCrossRefPubMed

22.

Simard S, Savard J (2009) Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17(3):241–251. https://doi.org/10.1007/s00520-008-0444-yCrossRefPubMed

23.

Lebel S, Rosberger Z, Edgar L, Devins GM (2009) Emotional distress impacts fear of the future among breast cancer survivors not the reverse. J Cancer Surviv 3(2):117–127. https://doi.org/10.1007/s11764-009-0082-5CrossRefPubMed

24.

Hall AE, Sanson-Fisher RW, Carey ML, Paul C, Williamson A, Bradstock K, Campbell HS (2016) Prevalence and associates of psychological distress in haematological cancer survivors. Support Care Cancer 24(10):4413–4422. https://doi.org/10.1007/s00520-016-3282-3CrossRefPubMed

25.

Boyes AW, Clinton-McHarg T, Waller AE, Steele A, D’Este CA, Sanson-Fisher RW (2015) Prevalence and correlates of the unmet supportive care needs of individuals diagnosed with a haematological malignancy. Acta Oncol 54(4):507–514. https://doi.org/10.3109/0284186x.2014.958527CrossRefPubMed

26.

Trevino KM, Fasciano K, Prigerson HG (2013) Patient-oncologist alliance, psychosocial well-being, and treatment adherence among young adults with advanced cancer. J Clin Oncol 31(13):1683. https://doi.org/10.1200/JCO.2012.46.7993CrossRefPubMedPubMedCentral

27.

Thewes B, Butow P, Bell ML, Beith J, Stuart-Harris R, Grossi M, Capp A, Dalley D, Committee FSA (2012) Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer 20(11):2651–2659. https://doi.org/10.1007/s00520-011-1371-xCrossRefPubMed

28.

Borreani C, Alfieri S, Farina L, Bianchi E, Corradini P (2020) Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors. Support Care Cancer 28(12):5973–5982. https://doi.org/10.1007/s00520-020-05434-9CrossRefPubMed

29.

Mutsaers B, Jones G, Rutkowski N, Tomei C, Leclair CS, Petricone-Westwood D, Simard S, Lebel S (2016) When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Support Care Cancer 24(10):4207–4218. https://doi.org/10.1007/s00520-016-3248-5CrossRefPubMed

30.

Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300–322. https://doi.org/10.1007/s11764-013-0272-zCrossRefPubMed

31.

Rudy L, Maheu C, Körner A, Lebel S, Gélinas C (2020) The FCR-1: Initial validation of a single-item measure of fear of cancer recurrence. Psycho-Oncol 29(4):788–795. https://doi.org/10.1002/pon.5350CrossRef

32.

Tzelepis F, Paul CL, Sanson-Fisher RW, Campbell HS, Bradstock K, Carey ML, Williamson A (2018) Unmet supportive care needs of haematological cancer survivors: rural versus urban residents. Ann Hematol 97(7):1283–1292. https://doi.org/10.1007/s00277-018-3285-xCrossRefPubMed

33.

Hamilton JG, Wu LM, Austin JE, Valdimarsdottir H, Basmajian K, Vu A, Rowley SD, Isola L, Redd WH, Rini C (2013) Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psycho-Oncol 22(4):911–921. https://doi.org/10.1002/pon.3091CrossRef

34.

Majhail NS, Rizzo JD, Hahn T, Lee SJ, McCarthy PL, Ammi M, Denzen E, Drexler R, Flesch S, James H (2013) Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 48(6):865–871. https://doi.org/10.1038/bmt.2012.248CrossRefPubMed

35.

Sharp L, Carsin AE, Timmons A (2013) Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psycho-oncol 22(4):745–755. https://doi.org/10.1002/pon.3055CrossRef

36.

De Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, Daugherty C (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120(20):3245–3253. https://doi.org/10.1002/cncr.28814CrossRefPubMed

37.

Cancer Council Victoria (2020) Don't delay campaign resources. https://www.cancervic.org.au/get-support/covid-19/dont-delay/assets.html. Accessed 17 November 2020

38.

United Kingdom National Health Service (2020) Don’t delay seeing a GP if you have signs and symptoms of cancer. https://www.leedsccg.nhs.uk/news/dont-delay-seeing-a-gp-if-you-have-signs-and-symptoms-of-cancer. Accessed 17 November 2020

39.

Sansom-Daly UM, Wakefield CE, McGill BC, Wilson HL, Patterson P (2016) Consensus among international ethical guidelines for the provision of videoconferencing-based mental health treatments. JMIR Mental Health 3(2):e17. https://doi.org/10.2196/mental.5481CrossRefPubMedPubMedCentral

40.

Butow PN, Phillips F, Schweder J, White K, Underhill C, Goldstein D (2012) Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer 20(1):1–22. https://doi.org/10.1007/s00520-011-1270-1CrossRefPubMed

41.

Royal Australian College of General Practitioners (2020) Fears for culturally and linguistically diverse patients avoiding healthcare due to COVID-19.https://www.racgp.org.au/gp-news/media-releases/2020-media-releases/july-2020/fears-for-culturally-and-linguistically-diverse-pa. Accessed 2020 1 December

Title: Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic
Authors: Nienke Zomerdijk
Michelle Jongenelis
Camille E. Short
Andrew Smith
Jane Turner
Kathryn Huntley
Publication date: 01-12-2021
Publisher: Springer Berlin Heidelberg
Keywords: Psycho-oncology
Psycho-oncology
Care
COVID-19
Anxiety
Published in: Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06369-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2021

Yoga therapy to reduce fatigue in cancer: effects of reminder e-mails and long-term efficacy

A pre-post evaluation of oncology healthcare providers’ knowledge, attitudes, and practices following the implementation of a complementary medicine practice guideline

YouTube as a source of information on breast cancer in the Arab world

The effect of massage therapy on fatigue after chemotherapy in gastrointestinal cancer patients

Recommendations for supportive care and best supportive care in NCCN clinical practice guidelines for treatment of cancer: Differences between solid tumor and hematologic malignancy guidelines

Trajectories of fatigue in a population-based sample of older adult breast, prostate, and colorectal cancer survivors: an analysis using the SEER-MHOS data resource

Keynote webinar | Spotlight on antibody–drug conjugates in cancer